On the recordMarch 29, 2023
In the Grassley-Wyden 2-year investigation into insulin price-gouging, we found that that PBM scheme encourages drug makers to spike the drug list price.
Source
congress.govIn the Grassley-Wyden 2-year investigation into insulin price-gouging, we found that that PBM scheme encourages drug makers to spike the drug list price.
Grassley discusses findings from an investigation into insulin pricing.
Share
More from Chuck Grassley
A U.S. Atty/district judge nominee without a blue slip does not have the votes to get confirmed on the Senate floor & they don’t have the votes to get out of [committee]. As chairman. I set Pres Trump noms up for SUCCESS NOT FAILURE.
We better put our heads together, or we’re going to lose the opportunity of getting E15.
Last night, I was surprised to see President Trump on Truth Social go after me and Senate Republicans over what we call the ‘blue slip,’
Based on the evidence to-date, Arctic Frost and related weaponization by federal law enforcement under Biden was arguably worse than Watergate.